THE PHARMACIST'S NEW AI ASSISTANT: A PARTNER OR CONTESTANT

dc.contributor.authorShatha Alqawasmeh
dc.contributor.authorTartel Anes khader Zaiton
dc.contributor.authorReema Alshweiki
dc.contributor.authorBahaa Al-Halawani
dc.date.accessioned2026-09-15T06:04:20Z
dc.date.available2026-09-15T06:04:20Z
dc.date.issued2026-05-12
dc.description.abstractIntroduction: In recent years, artificial intelligence (AI) has emerged as a transformative force across multiple sectors of life, from education and finance to transportation and health care. Among the most prominent innovations are large language models (LLMs) such as ChatGPT, Gemini, DeepSeek, and Copilot, which are capable of understanding and generating natural language with near-human proficiency Objective: The purpose of this study was to assess and compare the accuracy and efficiency of AI chatbot platforms vs. licensed pharmacists in answering pharmaceutical inquiries in different areas such as drug–drug interactions, adverse drug reactions, dose recommendations, prescriber clarification, contraindication, and patient counselling. Method: A comparative cross-sectional study was conducted in evaluated the accuracy of five AI chatbot platforms versus 273 licensed pharmacists in answering pharmaceutical consultation questions. Participants responded anonymously to a validated 14-question survey based on real-life clinical scenarios across multiple pharmacy domains. AI platforms were tested using Arabic inputs to reflect real-world patient interactions.
dc.identifier.urihttps://dspace.alquds.edu/handle/20.500.12213/10809
dc.language.isoen
dc.publisherDeanship of Scientific Research - Al-Quds University
dc.titleTHE PHARMACIST'S NEW AI ASSISTANT: A PARTNER OR CONTESTANT
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
THE PHARMACIST_S NEW AI ASSISTANT.pdf
Size:
201.82 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.61 KB
Format:
Item-specific license agreed upon to submission
Description: